Anggot, Cecillia .
HRN: 17-87-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2025
04/11/2025
IVT
4.5g
Q6
Sepsis Sec To Non Healing Wound Right Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes